C07D 273/08
Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only
Official title: having two nitrogen atoms and more than one oxygen atom
C07D273/08 (Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only) appears on 32 US grants and 41 published applications in this corpus.
Search patents in C07D- Granted patents
- 32
- Published applications
- 41
- Assignees
- 24
- Inventors
- 103
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 2 | 5 |
| 2012 | 0 | 4 |
| 2013 | 4 | 2 |
| 2014 | 1 | 2 |
| 2015 | 4 | 6 |
| 2016 | 3 | 2 |
| 2017 | 5 | 2 |
| 2018 | 1 | 1 |
| 2019 | 1 | 4 |
| 2020 | 2 | 2 |
| 2021 | 2 | 2 |
| 2022 | 2 | 0 |
| 2023 | 0 | 3 |
| 2024 | 1 | 2 |
| 2025 | 2 | 1 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic diamine derivatives as ENT inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonists25 Aug 2026US 12,715,880 B2iTeos Belgium SA
- 1,2,4-oxadiazole derivatives as immunomodulators2 Jun 2026US 12,643,870 B2Aurigene Oncology Limited
- Conjugated lipomers and uses thereof19 Aug 2025US 12,390,528 B2Massachusetts Institute of Technology
- Substituted antivirals for treating coronavirus infection21 Jan 2025US 12,202,808 B2Erasmus University Medical Center Rotterdam
- 1,2,4-oxadiazole derivatives as immunomodulators16 Jul 2024US 12,037,321 B2Aurigene Oncology Limited
- Spiromacrocyclic orexin 2 receptor agonists28 May 2026US 2026/0144795 A1H. Lundbeck A.S.
- Macrocyclic compounds and methods of making the same13 Mar 2025US 2025/0082793 A1Janssen Biotech, Inc.
- 1,2,4-Oxadiazole Derivatives as Immunomodulators5 Dec 2024US 2024/0400525 A1Aurigene Oncology Limited
- Metal complexes, and dishwashing products containing same3 Oct 2024US 2024/0327756 A1
- Macrocyclic diamine derivatives as ent inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonists29 Jun 2023US 2023/0203058 A1iTeos Belgium SA
Most cited
By later US patents
- Conjugates, preparation thereof, and therapeutic use thereof62US 8,952,147 B2Sanofi · 2015
- Conjugated lipomers and uses thereof23US 9,238,716 B2Massachusetts Institute of Technology · 2016
- 1,2,4-oxadiazole derivatives as immunomodulators19US 9,771,338 B2Auirgene Discovery Technologies Limited · 2017
- 1,2,4-oxadiazole derivatives as immunomodulators18US 10,173,989 B2Aurigene Discovery Technologies Limited · 2019
- 1,2,4-oxadiazole derivatives as immunomodulators16US 10,590,093 B2Aurigene Discovery Technologies Limited · 2020